Cemin R, Daves M. Pre-analytic variability in cardiovascular biomarker testing. J Thorac Dis. 2015 Oct;7(10):E395-401. \[[PMC free article: PMC4635305](/pmc/articles/PMC4635305/)\] \[[PubMed: 26623116](https://pubmed.ncbi.nlm.nih.gov/26623116)\] 35. Okamoto R, Ali Y, Hashizume R, Suzuki N, Ito M. BNP as a Major Player in the Heart-Kidney Connection. Int J Mol Sci. 2019 Jul 22;20(14) \[[PMC free article: PMC6678680](/pmc/articles/PMC6678680/)\] \[[PubMed: 31336656](https://pubmed.ncbi.nlm.nih.gov/31336656)\] 36. Keyzer JM, Hoffmann JJ, Ringoir L, Nabbe KC, Widdershoven JW, Pop VJ. Age- and gender-specific brain natriuretic peptide (BNP) reference ranges in primary care. Clin Chem Lab Med. 2014 Sep;52(9):1341-6. \[[PubMed: 24781675](https://pubmed.ncbi.nlm.nih.gov/24781675)\] 37. Madamanchi C, Alhosaini H, Sumida A, Runge MS. Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure. Int J Cardiol. 2014 Oct 20;176(3):611-7. \[[PMC free article: PMC4201035](/pmc/articles/PMC4201035/)\] \[[PubMed: 25156856](https://pubmed.ncbi.nlm.nih.gov/25156856)\] 38. Krauser DG, Lloyd-Jones DM, Chae CU, Cameron R, Anwaruddin S, Baggish AL, Chen A, Tung R, Januzzi JL. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J. 2005 Apr;149(4):744-50. \[[PubMed: 15990762](https://pubmed.ncbi.nlm.nih.gov/15990762)\] 39. Bayes-Genis A, Lloyd-Jones DM, van Kimmenade RR, Lainchbury JG, Richards AM, Ordoñez-Llanos J, Santaló M, Pinto YM, Januzzi JL. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea. Arch Intern Med. 2007 Feb 26;167(4):400-7. \[[PubMed: 17325303](https://pubmed.ncbi.nlm.nih.gov/17325303)\] 40. Semenov AG, Feygina EE. Standardization of BNP and NT-proBNP Immunoassays in Light of the Diverse and Complex Nature of Circulating BNP-Related Peptides. Adv Clin Chem. 2018;85:1-30. \[[PubMed: 29655458](https://pubmed.ncbi.nlm.nih.gov/29655458)\] 41. Tamm NN, Seferian KR, Semenov AG, Mukharyamova KS, Koshkina EV, Krasnoselsky MI, Postnikov AB, Serebryanaya DV, Apple FS, Murakami MM, Katrukha AG. Novel immunoassay for quantification of brain natriuretic peptide and its precursor in human blood. Clin Chem. 2008 Sep;54(9):1511-8. \[[PubMed: 18606632](https://pubmed.ncbi.nlm.nih.gov/18606632)\] 42. Cao Z, Jia Y, Zhu B. BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine. Int J Mol Sci. 2019 Apr 12;20(8) \[[PMC free article: PMC6515513](/pmc/articles/PMC6515513/)\] \[[PubMed: 31013779](https://pubmed.ncbi.nlm.nih.gov/31013779)\] 43. Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart. 2006 Jun;92(6):843-9. \[[PMC free article: PMC1860679](/pmc/articles/PMC1860679/)\] \[[PubMed: 16698841](https://pubmed.ncbi.nlm.nih.gov/16698841)\] 44. Luckenbill KN, Christenson RH, Jaffe AS, Mair J, Ordonez-Llanos J, Pagani F, Tate J, Wu AH, Ler R, Apple FS. Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac